Current Awareness

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of human psychopharmacology. Each bibliography is divided into 18 sections: 1 Books, Reviews & Symposia; 2 General; 3 Psychotropic Drugs ‐ General; Antidepressive Agents: 4 Tricyclics; 5 Monoamine Oxidase Inhibitors; 6 Serotonergics; Euthymic Agents: 7 Lithium; Tranquillizing Agents: 8 Major; 9 Minor & Hypnotics; 10 Analeptic Agents; 11 Anticonvulsant Agents; 12 Drugs of Abuse; 13 Transmitters, Receptors, Metabolites & Modulating Agents; 14 Neuropeptides; 15 Psychoneuroendocrinology; 16 Psychoneuroimmunology; 17 Behavioural Genetics; 18 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

[1]  Samuel E. Trosow.  Jurisdictional Disputes and the Unauthorized Practice of Law , 2001 .

[2]  J. Moore,et al.  Scottish Official Publications: An Introduction and Guide , 2001 .

[3]  B. Millet,et al.  Obsessive-compulsive disorder: evaluation of clinical and biological circadian parameters during fluoxetine treatment , 1999, Psychopharmacology.

[4]  T. Robbins,et al.  Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson’s disease , 1999, Psychopharmacology.

[5]  K. Silverman,et al.  Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude , 1999, Psychopharmacology.

[6]  B. Folley,et al.  Cerebral glucose metabolic and plasma catecholamine responses to the α2 adrenoceptor antagonist ethoxyidazoxan given to healthy volunteers , 1999, Psychopharmacology.

[7]  N. Swerdlow,et al.  Sex differences in sensorimotor gating of the human startle reflex: all smoke? , 1999, Psychopharmacology.

[8]  D. Nutt,et al.  Assessment of GABAA benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines , 1999, Psychopharmacology.

[9]  A. Young,et al.  Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers , 1999, Psychopharmacology.

[10]  I. Rosén,et al.  Electroencephalographic effects of intravenous nicotine – a dose-response study , 1999, Psychopharmacology.

[11]  S. Ikemoto,et al.  Increased sensitivity to stress and episode recurrence in spontaneous recurrence of methamphetamine psychosis , 1999, Psychopharmacology.

[12]  T. Robbins,et al.  The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers , 1999, Psychopharmacology.

[13]  K. Perkins,et al.  Effects of training dose and two- versus three-choice testing procedure on nicotine discrimination responding in humans , 1999, Psychopharmacology.

[14]  B. Jones,et al.  The effects of alcohol cues and an alcohol priming dose on a multi-factorial measure of subjective cue reactivity in social drinkers , 1999, Psychopharmacology.

[15]  B. Sahakian,et al.  Idazoxan potentiates rather than antagonizes some of the cognitive effects of clonidine , 1999, Psychopharmacology.

[16]  H. de Wit,et al.  Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women , 1999, Psychopharmacology.

[17]  Terry D. Blumenthal,et al.  Caffeine-associated stimuli elicit conditioned responses: an experimental model of the placebo effect , 1999, Psychopharmacology.

[18]  R. Griffiths,et al.  Zaleplon and triazolam in humans: acute behavioral effects and abuse potential , 1999, Psychopharmacology.

[19]  R. Dolan,et al.  Dissociating neuromodulatory effects of diazepam on episodic memory encoding and executive function , 1999, Psychopharmacology.

[20]  U. Schall,et al.  Effects of prepulses and d-amphetamine on performance and event-related potential measures on an auditory discrimination task , 1999, Psychopharmacology.

[21]  W. Bickel,et al.  Effects of response requirement and the availability of an alternative reinforcer on cigarette smoking by schizophrenics , 1999, Psychopharmacology.

[22]  M. Gunnar,et al.  Cortisol levels of young children in full-day childcare centers: relations with age and temperament , 1999, Psychoneuroendocrinology.

[23]  Fabio Macciardi,et al.  Association of the MscI Polymorphism of the Dopamine D3 Receptor Gene with Tardive Dyskinesia in Schizophrenia , 1999, Neuropsychopharmacology.

[24]  Malcolm Lader,et al.  The influences of age and caffeine on psychomotor and cognitive function , 1999, Psychopharmacology.

[25]  P. Cowen,et al.  Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors? , 1999, Psychopharmacology.

[26]  T. Dinan,et al.  Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. , 1999, Journal of affective disorders.

[27]  O. Koenig,et al.  Midazolam effects on implicit and explicit memory processes in healthy subjects , 1999, Psychopharmacology.

[28]  K. Schuh,et al.  Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans , 1999, Psychopharmacology.

[29]  D. Reis,et al.  Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients. , 1999, Journal of psychiatric research.

[30]  M. Jann,et al.  In-vitro and in-vivo evaluation of the drug-drug interaction between fluvoxamine and clozapine , 1999, Psychopharmacology.

[31]  D. Cyril D’Souza,et al.  Interactive effects of subanesthetic ketamine and haloperidol in healthy humans , 1999, Psychopharmacology.

[32]  G. Scherer.  Smoking behaviour and compensation: a review of the literature , 1999, Psychopharmacology.

[33]  K. Otani,et al.  Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients , 1999, Psychopharmacology.

[34]  Sandra K Loo,et al.  EEG correlates of methylphenidate response among children with ADHD: a preliminary report , 1999, Biological Psychiatry.

[35]  E. Demet,et al.  Pupillary cholinergic sensitivity to pilocarpine increases in manic lithium responders , 1999, Biological Psychiatry.

[36]  R. See,et al.  Risperidone-induced increase of plasma norepinephrine is not correlated with symptom improvement in chronic schizophrenia , 1999, Biological Psychiatry.

[37]  A. Egberts,et al.  Antidepressant drug choice for first users in two regions in the Netherlands , 1999, Pharmacy World and Science.

[38]  T. Dinan,et al.  The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression. , 1999, Journal of affective disorders.

[39]  Karl J. Friston,et al.  Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion , 1999, British Journal of Psychiatry.

[40]  C. Mercier-Guyon,et al.  Comparative Study of the Effects of Captodiamine and Lorazepam on Car Driving Ability , 1999 .

[41]  T. Dinan,et al.  Desmopressin augments pituitary–adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers , 1999, Biological Psychiatry.

[42]  N. Solowij,et al.  Event-related potential indices of auditory selective attention in dependent amphetamine users , 1999, Biological Psychiatry.

[43]  S. Morishita,et al.  Clonazepam in the treatment of prolonged depression. , 1999, Journal of affective disorders.

[44]  N. Pivac,et al.  Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients , 1999, Biological Psychiatry.

[45]  M. M.,et al.  Factors associated with medium‐term response to psychostimulant medication , 1999, Journal of paediatrics and child health.

[46]  T. Someya,et al.  Lower plasma levels of haloperidol in smoking than in nonsmoking schizophrenic patients. , 1999, Therapeutic drug monitoring.

[47]  D. Jeste,et al.  Lower Incidence of Tardive Dyskinesia with Risperidone Compared with Haloperidol in Older Patients , 1999, Journal of the American Geriatrics Society.

[48]  J. Zohar,et al.  Increased olfactory sensitivity in first episode psychosis and the effect of neuroleptic treatment on olfactory sensitivity in schizophrenia , 1999, Psychiatry Research.

[49]  S. Patten.  Exogenous corticosteroid exposures are associated with increased recollection of traumatic life events. , 1999, Journal of affective disorders.

[50]  B. Lerer,et al.  Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia , 1999, Molecular Psychiatry.

[51]  H. Silver,et al.  The effect of augmentation with moclobemide on symptoms of schizophrenia. , 1999, International clinical psychopharmacology.

[52]  M. Brüne.  The incidence of akathisia in bipolar affective disorder treated with neuroleptics--a preliminary report. , 1999, Journal of affective disorders.

[53]  R. Griffiths,et al.  Triazolam and zolpidem: effects on human memory and attentional processes , 1999, Psychopharmacology.

[54]  I. Matsuzaki,et al.  The Predictive Value of Benzodiazepine Tolerance in Persistently Aggressive Schizophrenia , 1999, Neuropsychobiology.

[55]  F. Engelsmann,et al.  Effect of lithium maintenance therapy on thyroid and parathyroid function. , 1999, Journal of psychiatry & neuroscience : JPN.

[56]  M. Koulu,et al.  Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism , 1999, Molecular Psychiatry.

[57]  B. Gulanski,et al.  The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group. , 1999, The Journal of clinical psychiatry.

[58]  W. Pritchard,et al.  A double blind study of the effects of smoking on heart rate: is there tachyphylaxis? , 1999, Psychopharmacology.

[59]  Trevor R. Norman,et al.  The effect of age and pre-light melatonin concentration on the melatonin sensitivity to dim light. , 1999, International Clinical Psychopharmacology.

[60]  C. Salzman,et al.  Effects of psychotropic medications on pancreatic function: a review. , 1999, Harvard review of psychiatry.

[61]  J. Russell,et al.  Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline. , 1999, The American journal of managed care.

[62]  J. Ballenger,et al.  Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. , 1999, Journal of Clinical Psychiatry.

[63]  Z. Cernovsky,et al.  Lithium dosage and leukocyte counts in psychiatric patients. , 1999, Journal of psychiatry & neuroscience : JPN.

[64]  T. Nielsen,et al.  Somnambulistic-like behaviour in patients attending a lithium clinic. , 1999, International clinical psychopharmacology.

[65]  A. Rush,et al.  Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project. , 1999, The Journal of clinical psychiatry.

[66]  D. Taylor,et al.  The effect of nefazodone on clozapine plasma concentrations. , 1999, International clinical psychopharmacology.

[67]  D. Nutt,et al.  Paroxetine and its uses in psychiatry. , 1999, Hospital medicine.

[68]  W. Riedel,et al.  Lithium induced cognitive side-effects in bipolar disorder: a qualitative analysis and implications for daily practice. , 1999, International clinical psychopharmacology.

[69]  R. Hirschfeld.  Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. , 1999, The Journal of clinical psychiatry.

[70]  P. Hjemdahl,et al.  Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment , 1999, Psychopharmacology.

[71]  E. Levin,et al.  Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer’s disease , 1999, Psychopharmacology.

[72]  W. Pritchard,et al.  Little evidence that “denicotinized” menthol cigarettes have pharmacological effects: an EEG/heart-rate/subjective-response study , 1999, Psychopharmacology.

[73]  O. Etard,et al.  Residual effects of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades , 1999, Psychopharmacology.

[74]  C. Robert Cloninger,et al.  Relationships of plasma tryptophan availability to course of illness and clinical features of alcoholism: a preliminary study , 1999, Psychopharmacology.

[75]  G. Hemmings,et al.  The CCK-A receptor gene possibly associated with auditory hallucinations in schizophrenia , 1999, European Psychiatry.

[76]  R. Suckow,et al.  Phenylalanine kinetics are associated with tardive dyskinesia in men but not in women , 1999, Psychopharmacology.

[77]  M. Geyer,et al.  Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans , 1999, Psychopharmacology.

[78]  R. Reid,et al.  Psychostimulant Use for Children with ADHD in Australia , 1999 .

[79]  K. Hutchison,et al.  Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans , 1999, Psychopharmacology.

[80]  U. McCann,et al.  Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study , 1999, Psychopharmacology.

[81]  A. Rodríguez-Fornells,et al.  Effects of alprazolam on the acoustic startle response in humans , 1999, Psychopharmacology.

[82]  M. Markianos,et al.  Gonadal axis hormones in male schizophrenic patients during treatment with haloperidol and after switch to risperidone , 1999, Psychopharmacology.

[83]  S. Comer,et al.  Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans , 1999, Psychopharmacology.

[84]  M. Maes,et al.  In vitro immunoregulatory effects of lithium in healthy volunteers , 1999, Psychopharmacology.

[85]  C. Bradshaw,et al.  Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man , 1999, Psychopharmacology.

[86]  L. Brauer,et al.  Naltrexone blockade of nicotine effects in cigarette smokers , 1999, Psychopharmacology.

[87]  M. Lambert,et al.  Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia , 1999, European Psychiatry.

[88]  J. Davidson,et al.  Quality of Life and Posttraumatic Stress Disorder: A Pilot Study Assessing Changes in SF-36 Scores Before and After Treatment in a Placebo-Controlled Trial of Fluoxetine , 1999, Journal of traumatic stress.

[89]  N. Majkić-Singh,et al.  Serum β-endorphin level in patients with depression on fluvoxamine , 1999 .

[90]  G. Kobal,et al.  Dose-dependent stereoselective activation of the trigeminal sensory system by nicotine in man , 1999, Psychopharmacology.

[91]  R. Maddock,et al.  Clonazepam Treatment of Panic Disorder in Patients with Recurrent Chest Pain and Normal Coronary Arteries , 1999, International journal of psychiatry in medicine.

[92]  Stephanie O’Malley,et al.  Stress-induced craving and stress response in cocaine dependent individuals , 1999, Psychopharmacology.

[93]  G. Gigerenzer,et al.  Specific attentional dysfunction in adults following early start of cannabis use , 1999, Psychopharmacology.

[94]  Hinderk M. Emrich,et al.  Effects of synthetic Δ9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man , 1999, Psychopharmacology.

[95]  Andrew P. Smith,et al.  The effects of idazoxan on reaction times, eye movements and the mood of healthy volunteers and patients with upper respiratory tract illnesses , 1999, Journal of psychopharmacology.

[96]  J. Corwin,et al.  Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer’s disease , 1999, Psychopharmacology.

[97]  M. Haney,et al.  Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans , 1999, Psychopharmacology.

[98]  A. Young,et al.  Effects of dexamethasone on neuroendocrine and psychological responses to L-tryptophan infusion , 1999, Psychopharmacology.

[99]  J. Alvarez,et al.  Plasma serotonin level after 1 day of fluoxetine treatment: a biological predictor for antidepressant response? , 1999, Psychopharmacology.

[100]  Y. Okamoto,et al.  The relationship of the platelet 5-HT-induced calcium response to clinical symptoms in eating disorders , 1999, Psychopharmacology.

[101]  J. Deakin,et al.  Comparison of buspirone with diazepam and fluvoxamine on aversive classical conditioning in humans , 1999, Journal of psychopharmacology.

[102]  J. Vieth,et al.  Spontaneous slow and fast MEG activity in male schizophrenics treated with clozapine , 1999, Psychopharmacology.

[103]  R. Dunn,et al.  Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines , 1999, Journal of psychopharmacology.

[104]  B. Tiplady,et al.  Single dose pharmacodynamics of thioridazine and remoxipride in healthy younger and older volunteers , 1999, Journal of psychopharmacology.

[105]  B. Lerer,et al.  Clinical doses of fluoxetine and cerebral blood flow in healthy volunteers , 1999, Psychopharmacology.

[106]  J. Sheikh,et al.  Treatment of Panic Disorder in Older Adults: A Pilot Study Comparison of Alprazolam, Imipramine, and Placebo , 1999, International journal of psychiatry in medicine.

[107]  Ezio Tirelli,et al.  Selective effects of nicotine on attentional processes , 1999, Psychopharmacology.

[108]  A. Sirota,et al.  Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results , 1999, Psychopharmacology.

[109]  P. Renshaw,et al.  Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report , 1999, Psychopharmacology.

[110]  Ezio Tirelli,et al.  Effects of nicotine administered via a transdermal delivery system on vigilance: a repeated measure study , 1999, Psychopharmacology.

[111]  Richard W. Foltin,et al.  Abstinence symptoms following smoked marijuana in humans , 1999, Psychopharmacology.

[112]  M. Stitzer,et al.  Manipulation of cigarette craving through rapid smoking: efficacy and effects on smoking behavior , 1999, Psychopharmacology.

[113]  A. Cleare,et al.  Peripheral hormonal responses to D-fenfluramine as a probe of central serotonergic function in humans , 1999, Psychopharmacology.

[114]  E. Gouzoulis-Mayfrank,et al.  Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers Results of an experimental double-blind placebo-controlled study , 1999, Psychopharmacology.

[115]  F. Moeller,et al.  Prolactin response to buspirone was reduced in violent compared to nonviolent parolees , 1999, Psychopharmacology.

[116]  S. Evers,et al.  The impact of ergotamine-induced headache and ergotamine withdrawal on information processing , 1999, Psychopharmacology.

[117]  K. Perkins,et al.  Effects of central and peripheral nicotinic blockade on human nicotine discrimination , 1999, Psychopharmacology.

[118]  M. Haney,et al.  Abstinence symptoms following oral THC administration to humans , 1999, Psychopharmacology.

[119]  K. Hawkins,et al.  Health status and health care costs for publicly funded patients with schizophrenia started on clozapine. , 1998, Psychiatric services.

[120]  M. Trimble,et al.  Effects of gabapentin on cognition and quality of life in patients with epilepsy , 1998, Seizure.

[121]  A. Diosy.  Monoamine oxidase inhibitors , 1984 .

[122]  Pedro Parraguez Ruiz,et al.  Ethnic Differences in the Neuroleptic Treatment of Schizophrenia , 2004, Psychiatric Quarterly.

[123]  R. Hu.  PR for Academic Libraries: Focus on the Faculty , 2002 .

[124]  S. Thorpe.  Trends in Law Library Public Services: Have You Seen Your Patrons Lately?, , 2002 .

[125]  James S. Heller.  Collection Development and Weeding a la Versace: Fashioning a Policy for Your Library , 2002 .

[126]  Sheri H. Lewis.  A Three-Tiered Approach to Faculty Services Librarianship in the Law School Environment , 2002 .

[127]  Mary Rumsey.  Runaway Train: Problems of Permanence, Accessibility, and Stability in the Use of Web Sources in Law Review Citations , 2002 .

[128]  G. J. Pearson.  Rohn's World Treaty Index: Its Past and Future , 2001, International Journal of Legal Information.

[129]  W. H. Robinson.  Legislative Research: Essential Roles and Standards of Excellence , 2001, International Journal of Legal Information : Official Publication.

[130]  F. Shapiro.  Collected papers on legal citation analysis , 2001 .

[131]  C. Cappa.  Weblaw: A subject gateway to Australian legal resources , 2001 .

[132]  G. Engström,et al.  Blood folate, vitamin B12, and their relationships with cerebrospinal fluid monoamine metabolites, depression, and personality in suicide attempters , 1999 .

[133]  S. Marder,et al.  Risperidone versus haloperidol on secondary memory: can newer medications aid learning? , 1999, Schizophrenia bulletin.

[134]  岡本 百合.  The relationship of the platelet 5-HT-induced calcium response to clinical symptoms in eating disorders , 1999 .

[135]  H. Meltzer,et al.  The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. , 1999, Schizophrenia bulletin.

[136]  R. Conley,et al.  Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months. , 1998, Journal of child and adolescent psychopharmacology.

[137]  C. Arpino,et al.  Prescription of neuroleptics for children and adolescents in Italy. , 1998, Journal of child and adolescent psychopharmacology.

[138]  A. Sondheimer.  Clomipramine treatment of delusional disorder-somatic type. , 1988, Journal of the American Academy of Child and Adolescent Psychiatry.

[139]  Edward J. Jennerich.  The Art of the Reference Interview , 1981 .

[140]  G. Erlande.  [Tranquillizing agents]. , 1957, Marseille medical.

[141]  the Menstrual Cycle of Women , 2022 .